Our founders have complimentary skills in genomic medicine, computational analysis, pharmaceutical development, clinical neurology and biomedical entrepreneurship.
Dr Louwai Muhammed
Neurologist with a background in biomedical entrepreneurship. Studied neuroscience at Cambridge and clinical medicine at Oxford. Graduated top of his year and was the first medical student in Oxford history to be awarded merits in every exam. Top ranking applicant to London academic medical training and was the highest scoring applicant to neurology specialist training in the UK. Awarded a Kennedy Scholarship to complete a Master's degree at Harvard University, studying entrepreneurship, negotiation and communication. He won the MIT $100K Accelerate Entrepreneurship Competition in Boston by inventing a neurological device and creating an award-winning business-plan. He also founded an internationally recognised teaching platform for medical students in war-zones.
Dr Liisi Blevins
PhD from Imperial College London in Computational Systems Biology. Over 7-years of research on brain tumours, glioma microenvironments and vasculature, cancer genetics and pathways of malignant transformation. Studied neuroscience in Karolinska Institute, medical science in Uppsala University and was ranked first in genetics at University of Tartu, graduating cum laude. Awarded multiple scholarships including the highly competitive Imperial College President's scholarship.
Professor Michael Johnson
Professor of Neurology and Genomic Medicine at Imperial College London with over 15-years experience with pharma and biotech in paid consultancies, scientific and commercial advisory boards, research collaborations and clinical development including randomized controlled trials. Graduated from Oxford (PhD in molecular genetics) and St Bartholomew's Hospital Medical School (Medicine). Over 20-years experience as Principle Investigator at Imperial College in genetics and genomics and as a consultant clinical neurologist at Imperial College Healthcare. Professor Johnson pioneered the development of applied systems biology for drug discovery with over 75 journal articles and book chapters including in Nature, Nature Genetics, Nature Neuroscience, Nature Communications, Genome Research and Nature Reviews Neurology.